Can non-holders show us another outlet that dares to 'guarantee saving up to 40%",
then they prove they have some research-credibility?
.
These say it all how good Intiger is.
1) Thanks to@Active Investor, 24633066
"Regarding Sentry
Pilot completed successfully
There was no dissatisfaction by Sentry
Sentry practices have been approved to engage IAM if they want to do so
Discussions ongoing business relationship with Sentry office
Regarding NAB
Completed pilot work
Discussing future work
MOU 2, 3, 4, 5, 6 still talking. MOU 2 has completed their 19 steps; IAM in discussion with MOU 2 decision makers..."
.
2) Thanks @baxtermail , 24554208
" 9. The online portal will provide scale.
Lilly is a full service offering aimed at licensees, while the online portal is aimed at individual practices and practices under licensees who have not yet got licensee approval for Lilly.
Lilly is time consuming to implement into each business because it requires practises to change their processes.
The online portal requires no implementation and makes ordering a statement of advise as easy as ordering a dominos pizza.
Hence the low cost growth potential..."
( Portal oh Portal, where are thou? =)
.
3) More research by various attendees , compiled by @HenryA , 24671292
.
Cheers.
- Forums
- ASX - By Stock
- CF1
- Melbourne Roadshow
Melbourne Roadshow, page-98
Featured News
Add CF1 (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.33M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 844127 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 174052 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 844127 | 0.025 |
2 | 543750 | 0.024 |
1 | 75000 | 0.023 |
1 | 250000 | 0.021 |
1 | 103307 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 174052 | 1 |
0.029 | 280000 | 1 |
0.030 | 500000 | 1 |
0.040 | 100000 | 1 |
0.044 | 500000 | 1 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online